FDA Wants Companies to Simplify Drug Packaging, Naming, and Labeling To Reduce Medication Errors

Documenti analoghi

• Drug Companies Worry About New “Totality of Evidence” Standard: Is It an About–Face From the FDA on Off-Label Promotion?
  di: Barlas, Stephen
  Pubblicazione: (2017)
• Brand and Generics Companies Unite to Pressure FDA: They Want the Agency to Drop Its Safety-Label Plan and Adopt Their Alternative
  di: Barlas, Stephen
  Pubblicazione: (2015)
• FDA Finalizes Drug Communication Guidance: P&T Committees Can Receive Data Beyond the Drug Label
  di: Barlas, Stephen
  Pubblicazione: (2018)
• FDA Plans to Simplify Formats For Consumer Pharmacy Materials
  di: Barlas, Stephen
  Pubblicazione: (2010)
• ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS
  di: R. N. Alyautdin, et al.
  Pubblicazione: (2022-06-01)